These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic. Bellavia MC; Patel RB; Anderson CJ J Nucl Med; 2022 Nov; 63(11):1636-1641. PubMed ID: 36215570 [TBL] [Abstract][Full Text] [Related]
6. Integrin α Chen H; Zhao L; Fu K; Lin Q; Wen X; Jacobson O; Sun L; Wu H; Zhang X; Guo Z; Lin Q; Chen X Theranostics; 2019; 9(25):7948-7960. PubMed ID: 31695808 [TBL] [Abstract][Full Text] [Related]
7. Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment. Kleinendorst SC; Oosterwijk E; Bussink J; Westdorp H; Konijnenberg MW; Heskamp S Clin Cancer Res; 2022 Sep; 28(17):3652-3657. PubMed ID: 35471557 [TBL] [Abstract][Full Text] [Related]
8. Introduction to radiobiology of targeted radionuclide therapy. Pouget JP; Lozza C; Deshayes E; Boudousq V; Navarro-Teulon I Front Med (Lausanne); 2015; 2():12. PubMed ID: 25853132 [TBL] [Abstract][Full Text] [Related]
9. Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer. Damiana TST; Dalm SU Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34067215 [TBL] [Abstract][Full Text] [Related]
10. Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Carlson PM; Patel RB; Birstler J; Rodriquez M; Sun C; Erbe AK; Bates AM; Marsh I; Grudzinski J; Hernandez R; Pieper AA; Feils AS; Rakhmilevich AL; Weichert JP; Bednarz BP; Sondel PM; Morris ZS J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639155 [TBL] [Abstract][Full Text] [Related]
14. Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment. Ruigrok EAM; Verkaik NS; de Blois E; de Ridder C; Stuurman D; Roobol SJ; Van Gent DC; de Jong M; Van Weerden WM; Nonnekens J Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887398 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT). Grzmil M; Boersema P; Sharma A; Blanc A; Imobersteg S; Pruschy M; Picotti P; Schibli R; Behe M J Hematol Oncol; 2022 Aug; 15(1):123. PubMed ID: 36045419 [TBL] [Abstract][Full Text] [Related]
16. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884 [TBL] [Abstract][Full Text] [Related]
17. The Promise of Combining Radiation Therapy With Immunotherapy. Jagodinsky JC; Harari PM; Morris ZS Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):6-16. PubMed ID: 32335187 [TBL] [Abstract][Full Text] [Related]
18. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy. Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F Front Immunol; 2023; 14():1289434. PubMed ID: 38304255 [TBL] [Abstract][Full Text] [Related]
19. Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments. Jagodinsky JC; Morris ZS Semin Radiat Oncol; 2020 Apr; 30(2):181-186. PubMed ID: 32381297 [TBL] [Abstract][Full Text] [Related]
20. Case Report: Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH Front Immunol; 2021; 12():752563. PubMed ID: 35003064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]